🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
450
TAKEDA PHARMACEUTICAL CO LTD
AVG HISTORICAL GAP
-0.55%
MAX GAP RECORD
-3.64%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $4502.T
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$4502.T
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (BEFORE OPEN) |
+0.21%
|
| Jul 30, 2026 Earnings Release 2026-07-30 (BEFORE OPEN) |
-1.44%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
-1.31%
|
| Jan 29, 2026 Earnings Release 2026-01-29 (BEFORE OPEN) |
+0.59%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN) |
+0.07%
|
| Jul 30, 2025 Earnings Release 2025-07-30 (AFTER CLOSE) |
-3.19%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+0.00%
|
| Jan 30, 2025 Earnings Release 2025-01-30 (AFTER CLOSE) |
+1.48%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.1%
Bullish Gaps (2)
Bearish Gaps (5)
Neutral / Flat (8)
📖 Intelligence Summary
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi,…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗